Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

The Effect of Nexium [esomeprazole] and Cardi-04 Yoghurt on Insulin Secretion and Effect and Cardi Vascular Risk Factors Associated With the Insulin Syndrome in Patients With Type 2 Diabetes - a Randomized Double-Blind, Prospective, Placebo Controlled 2 x 2 Factorial Design 3 Month's Study [Effekten af Nexium og Cardi 04- Yoghurt på insulin sekretion og - virkning samt CVD risikofatorer associeret med insulinresistens syndromet for patienter med type 2 diabetes - Et randomiseret, dobbeltblindet, prospektivt, placebokontrolleret 2 x 2 faktorielt design 3 måneders studium]

Next Previous
Trial Profile

The Effect of Nexium [esomeprazole] and Cardi-04 Yoghurt on Insulin Secretion and Effect and Cardi Vascular Risk Factors Associated With the Insulin Syndrome in Patients With Type 2 Diabetes - a Randomized Double-Blind, Prospective, Placebo Controlled 2 x 2 Factorial Design 3 Month's Study [Effekten af Nexium og Cardi 04- Yoghurt på insulin sekretion og - virkning samt CVD risikofatorer associeret med insulinresistens syndromet for patienter med type 2 diabetes - Et randomiseret, dobbeltblindet, prospektivt, placebokontrolleret 2 x 2 faktorielt design 3 måneders studium]

Status: Completed
Phase of Trial: Phase III

Latest Information Update: 18 Sep 2021

Price :
$35 *
Note:
  • Adis is an information provider.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
  • A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

  • Drugs Esomeprazole (Primary) ; Yogurt
  • Indications Diabetic complications; Type 2 diabetes mellitus
  • Focus Biomarker; Pharmacodynamics

Most Recent Events

  • 07 Nov 2012 Planned number of patients changed from 36 to 48.
  • 26 Sep 2012 Primary endpoint 'AUC-insulin' has not been met.
  • 26 Sep 2012 Results published in Diabetologia.

You need to be a logged in or subscribed to view this content

Request demo (opens in a new window)
If your organization or you do not have a subscription, try one of the following: If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top